nodes	percent_of_prediction	percent_of_DWPC	metapath
Lacosamide—CA3—prostate gland—urinary bladder cancer	0.018	0.0725	CbGeAlD
Lacosamide—CA14—prostate gland—urinary bladder cancer	0.0164	0.0659	CbGeAlD
Lacosamide—SCN9A—prostate gland—urinary bladder cancer	0.016	0.0645	CbGeAlD
Lacosamide—CA14—seminal vesicle—urinary bladder cancer	0.0138	0.0557	CbGeAlD
Lacosamide—Aspartame—TRPV1—urinary bladder cancer	0.0129	0.83	CrCbGaD
Lacosamide—CA5B—prostate gland—urinary bladder cancer	0.0114	0.0461	CbGeAlD
Lacosamide—SCN3A—prostate gland—urinary bladder cancer	0.0111	0.0448	CbGeAlD
Lacosamide—CA9—female reproductive system—urinary bladder cancer	0.00941	0.0379	CbGeAlD
Lacosamide—CA3—vagina—urinary bladder cancer	0.00889	0.0358	CbGeAlD
Lacosamide—CA4—prostate gland—urinary bladder cancer	0.0079	0.0318	CbGeAlD
Lacosamide—CA5B—urethra—urinary bladder cancer	0.00766	0.0308	CbGeAlD
Lacosamide—SCN3A—renal system—urinary bladder cancer	0.00758	0.0305	CbGeAlD
Lacosamide—CA1—renal system—urinary bladder cancer	0.00689	0.0277	CbGeAlD
Lacosamide—CA4—seminal vesicle—urinary bladder cancer	0.00668	0.0269	CbGeAlD
Lacosamide—CA2—prostate gland—urinary bladder cancer	0.00655	0.0264	CbGeAlD
Lacosamide—CA5B—female reproductive system—urinary bladder cancer	0.00625	0.0251	CbGeAlD
Lacosamide—SCN3A—female reproductive system—urinary bladder cancer	0.00607	0.0244	CbGeAlD
Lacosamide—CA3—lymph node—urinary bladder cancer	0.00575	0.0232	CbGeAlD
Lacosamide—CA5B—vagina—urinary bladder cancer	0.00565	0.0227	CbGeAlD
Lacosamide—CA2—seminal vesicle—urinary bladder cancer	0.00554	0.0223	CbGeAlD
Lacosamide—CA1—female reproductive system—urinary bladder cancer	0.00552	0.0222	CbGeAlD
Lacosamide—SCN3A—vagina—urinary bladder cancer	0.00549	0.0221	CbGeAlD
Lacosamide—CA4—renal system—urinary bladder cancer	0.00538	0.0217	CbGeAlD
Lacosamide—CA4—urethra—urinary bladder cancer	0.00529	0.0213	CbGeAlD
Lacosamide—SCN9A—lymph node—urinary bladder cancer	0.00512	0.0206	CbGeAlD
Lacosamide—CA2—epithelium—urinary bladder cancer	0.00481	0.0194	CbGeAlD
Lacosamide—CA2—smooth muscle tissue—urinary bladder cancer	0.00464	0.0187	CbGeAlD
Lacosamide—CA2—renal system—urinary bladder cancer	0.00446	0.018	CbGeAlD
Lacosamide—CA4—female reproductive system—urinary bladder cancer	0.00431	0.0174	CbGeAlD
Lacosamide—SCN10A—lymph node—urinary bladder cancer	0.0039	0.0157	CbGeAlD
Lacosamide—CA5B—lymph node—urinary bladder cancer	0.00365	0.0147	CbGeAlD
Lacosamide—CA2—female reproductive system—urinary bladder cancer	0.00358	0.0144	CbGeAlD
Lacosamide—SCN3A—lymph node—urinary bladder cancer	0.00355	0.0143	CbGeAlD
Lacosamide—CA2—vagina—urinary bladder cancer	0.00323	0.013	CbGeAlD
Lacosamide—CA1—lymph node—urinary bladder cancer	0.00323	0.013	CbGeAlD
Lacosamide—Nateglinide—PPARG—urinary bladder cancer	0.00263	0.169	CrCbGaD
Lacosamide—CA4—lymph node—urinary bladder cancer	0.00252	0.0102	CbGeAlD
Lacosamide—CA2—lymph node—urinary bladder cancer	0.00209	0.00842	CbGeAlD
Lacosamide—Discomfort—Cisplatin—urinary bladder cancer	0.00128	0.00216	CcSEcCtD
Lacosamide—Affect lability—Epirubicin—urinary bladder cancer	0.00128	0.00215	CcSEcCtD
Lacosamide—Urticaria—Thiotepa—urinary bladder cancer	0.00126	0.00212	CcSEcCtD
Lacosamide—Vertigo—Etoposide—urinary bladder cancer	0.00125	0.00211	CcSEcCtD
Lacosamide—Body temperature increased—Thiotepa—urinary bladder cancer	0.00125	0.00211	CcSEcCtD
Lacosamide—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.00125	0.00211	CcSEcCtD
Lacosamide—Mood swings—Epirubicin—urinary bladder cancer	0.00123	0.00207	CcSEcCtD
Lacosamide—Loss of consciousness—Etoposide—urinary bladder cancer	0.00122	0.00207	CcSEcCtD
Lacosamide—Ataxia—Epirubicin—urinary bladder cancer	0.00122	0.00206	CcSEcCtD
Lacosamide—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00122	0.00205	CcSEcCtD
Lacosamide—Skin disorder—Cisplatin—urinary bladder cancer	0.00121	0.00204	CcSEcCtD
Lacosamide—Insomnia—Gemcitabine—urinary bladder cancer	0.0012	0.00203	CcSEcCtD
Lacosamide—Diplopia—Doxorubicin—urinary bladder cancer	0.0012	0.00203	CcSEcCtD
Lacosamide—Osteoarthritis—Doxorubicin—urinary bladder cancer	0.0012	0.00203	CcSEcCtD
Lacosamide—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.0012	0.00203	CcSEcCtD
Lacosamide—Liver function test abnormal—Epirubicin—urinary bladder cancer	0.0012	0.00202	CcSEcCtD
Lacosamide—Paraesthesia—Gemcitabine—urinary bladder cancer	0.0012	0.00202	CcSEcCtD
Lacosamide—Chest pain—Etoposide—urinary bladder cancer	0.00119	0.002	CcSEcCtD
Lacosamide—Eosinophilia—Methotrexate—urinary bladder cancer	0.00119	0.002	CcSEcCtD
Lacosamide—Insomnia—Fluorouracil—urinary bladder cancer	0.00118	0.002	CcSEcCtD
Lacosamide—Somnolence—Gemcitabine—urinary bladder cancer	0.00118	0.002	CcSEcCtD
Lacosamide—Affect lability—Doxorubicin—urinary bladder cancer	0.00118	0.00199	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.00118	0.00199	CcSEcCtD
Lacosamide—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00118	0.00198	CcSEcCtD
Lacosamide—Discomfort—Etoposide—urinary bladder cancer	0.00117	0.00198	CcSEcCtD
Lacosamide—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.00117	0.00197	CcSEcCtD
Lacosamide—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00117	0.00197	CcSEcCtD
Lacosamide—Somnolence—Fluorouracil—urinary bladder cancer	0.00116	0.00196	CcSEcCtD
Lacosamide—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00115	0.00195	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00115	0.00194	CcSEcCtD
Lacosamide—Fatigue—Gemcitabine—urinary bladder cancer	0.00115	0.00194	CcSEcCtD
Lacosamide—Confusional state—Etoposide—urinary bladder cancer	0.00115	0.00194	CcSEcCtD
Lacosamide—Constipation—Gemcitabine—urinary bladder cancer	0.00114	0.00192	CcSEcCtD
Lacosamide—Mood swings—Doxorubicin—urinary bladder cancer	0.00114	0.00192	CcSEcCtD
Lacosamide—Asthenia—Thiotepa—urinary bladder cancer	0.00114	0.00192	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00113	0.00191	CcSEcCtD
Lacosamide—Ataxia—Doxorubicin—urinary bladder cancer	0.00113	0.0019	CcSEcCtD
Lacosamide—Neutropenia—Methotrexate—urinary bladder cancer	0.00112	0.00189	CcSEcCtD
Lacosamide—Pruritus—Thiotepa—urinary bladder cancer	0.00112	0.00189	CcSEcCtD
Lacosamide—Paraesthesia—Cisplatin—urinary bladder cancer	0.00111	0.00188	CcSEcCtD
Lacosamide—Eosinophilia—Epirubicin—urinary bladder cancer	0.00111	0.00187	CcSEcCtD
Lacosamide—Liver function test abnormal—Doxorubicin—urinary bladder cancer	0.00111	0.00187	CcSEcCtD
Lacosamide—Skin disorder—Etoposide—urinary bladder cancer	0.0011	0.00186	CcSEcCtD
Lacosamide—Hyperhidrosis—Etoposide—urinary bladder cancer	0.0011	0.00186	CcSEcCtD
Lacosamide—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.0011	0.00185	CcSEcCtD
Lacosamide—Diarrhoea—Thiotepa—urinary bladder cancer	0.00108	0.00183	CcSEcCtD
Lacosamide—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.00108	0.00182	CcSEcCtD
Lacosamide—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00108	0.00182	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00107	0.00181	CcSEcCtD
Lacosamide—Depression—Methotrexate—urinary bladder cancer	0.00106	0.0018	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.00106	0.00179	CcSEcCtD
Lacosamide—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00105	0.00178	CcSEcCtD
Lacosamide—Neutropenia—Epirubicin—urinary bladder cancer	0.00105	0.00177	CcSEcCtD
Lacosamide—Dizziness—Thiotepa—urinary bladder cancer	0.00105	0.00177	CcSEcCtD
Lacosamide—Urticaria—Fluorouracil—urinary bladder cancer	0.00104	0.00176	CcSEcCtD
Lacosamide—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00103	0.00175	CcSEcCtD
Lacosamide—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00103	0.00173	CcSEcCtD
Lacosamide—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00102	0.00173	CcSEcCtD
Lacosamide—Paraesthesia—Etoposide—urinary bladder cancer	0.00102	0.00172	CcSEcCtD
Lacosamide—Somnolence—Etoposide—urinary bladder cancer	0.00101	0.00171	CcSEcCtD
Lacosamide—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.00101	0.0017	CcSEcCtD
Lacosamide—Vomiting—Thiotepa—urinary bladder cancer	0.00101	0.0017	CcSEcCtD
Lacosamide—Rash—Thiotepa—urinary bladder cancer	0.000998	0.00168	CcSEcCtD
Lacosamide—Dermatitis—Thiotepa—urinary bladder cancer	0.000997	0.00168	CcSEcCtD
Lacosamide—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000996	0.00168	CcSEcCtD
Lacosamide—Headache—Thiotepa—urinary bladder cancer	0.000992	0.00167	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000991	0.00167	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000982	0.00166	CcSEcCtD
Lacosamide—Body temperature increased—Cisplatin—urinary bladder cancer	0.000981	0.00166	CcSEcCtD
Lacosamide—Fatigue—Etoposide—urinary bladder cancer	0.00098	0.00165	CcSEcCtD
Lacosamide—Constipation—Etoposide—urinary bladder cancer	0.000972	0.00164	CcSEcCtD
Lacosamide—Neutropenia—Doxorubicin—urinary bladder cancer	0.00097	0.00164	CcSEcCtD
Lacosamide—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000965	0.00163	CcSEcCtD
Lacosamide—Hepatitis—Methotrexate—urinary bladder cancer	0.000959	0.00162	CcSEcCtD
Lacosamide—Asthenia—Gemcitabine—urinary bladder cancer	0.000955	0.00161	CcSEcCtD
Lacosamide—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000945	0.0016	CcSEcCtD
Lacosamide—Pruritus—Gemcitabine—urinary bladder cancer	0.000942	0.00159	CcSEcCtD
Lacosamide—Nausea—Thiotepa—urinary bladder cancer	0.00094	0.00159	CcSEcCtD
Lacosamide—Feeling abnormal—Etoposide—urinary bladder cancer	0.000937	0.00158	CcSEcCtD
Lacosamide—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000933	0.00157	CcSEcCtD
Lacosamide—Pruritus—Fluorouracil—urinary bladder cancer	0.000926	0.00156	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000917	0.00155	CcSEcCtD
Lacosamide—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000914	0.00154	CcSEcCtD
Lacosamide—Bradycardia—Epirubicin—urinary bladder cancer	0.000913	0.00154	CcSEcCtD
Lacosamide—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000911	0.00154	CcSEcCtD
Lacosamide—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000906	0.00153	CcSEcCtD
Lacosamide—Urticaria—Etoposide—urinary bladder cancer	0.000903	0.00152	CcSEcCtD
Lacosamide—Body temperature increased—Etoposide—urinary bladder cancer	0.000899	0.00152	CcSEcCtD
Lacosamide—Hepatitis—Epirubicin—urinary bladder cancer	0.000897	0.00151	CcSEcCtD
Lacosamide—Eye disorder—Methotrexate—urinary bladder cancer	0.000896	0.00151	CcSEcCtD
Lacosamide—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000896	0.00151	CcSEcCtD
Lacosamide—Tinnitus—Methotrexate—urinary bladder cancer	0.000894	0.00151	CcSEcCtD
Lacosamide—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000893	0.00151	CcSEcCtD
Lacosamide—Asthenia—Cisplatin—urinary bladder cancer	0.00089	0.0015	CcSEcCtD
Lacosamide—Cardiac disorder—Methotrexate—urinary bladder cancer	0.00089	0.0015	CcSEcCtD
Lacosamide—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000882	0.00149	CcSEcCtD
Lacosamide—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000874	0.00148	CcSEcCtD
Lacosamide—Immune system disorder—Methotrexate—urinary bladder cancer	0.000866	0.00146	CcSEcCtD
Lacosamide—Dizziness—Fluorouracil—urinary bladder cancer	0.000866	0.00146	CcSEcCtD
Lacosamide—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000863	0.00146	CcSEcCtD
Lacosamide—Diarrhoea—Cisplatin—urinary bladder cancer	0.000849	0.00143	CcSEcCtD
Lacosamide—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000848	0.00143	CcSEcCtD
Lacosamide—Vomiting—Gemcitabine—urinary bladder cancer	0.000847	0.00143	CcSEcCtD
Lacosamide—Bradycardia—Doxorubicin—urinary bladder cancer	0.000845	0.00143	CcSEcCtD
Lacosamide—Mental disorder—Methotrexate—urinary bladder cancer	0.00084	0.00142	CcSEcCtD
Lacosamide—Rash—Gemcitabine—urinary bladder cancer	0.00084	0.00142	CcSEcCtD
Lacosamide—Dermatitis—Gemcitabine—urinary bladder cancer	0.000839	0.00142	CcSEcCtD
Lacosamide—Eye disorder—Epirubicin—urinary bladder cancer	0.000838	0.00142	CcSEcCtD
Lacosamide—Hypersensitivity—Etoposide—urinary bladder cancer	0.000838	0.00141	CcSEcCtD
Lacosamide—Tinnitus—Epirubicin—urinary bladder cancer	0.000836	0.00141	CcSEcCtD
Lacosamide—Erythema—Methotrexate—urinary bladder cancer	0.000834	0.00141	CcSEcCtD
Lacosamide—Headache—Gemcitabine—urinary bladder cancer	0.000834	0.00141	CcSEcCtD
Lacosamide—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000833	0.00141	CcSEcCtD
Lacosamide—Vomiting—Fluorouracil—urinary bladder cancer	0.000832	0.00141	CcSEcCtD
Lacosamide—Hepatitis—Doxorubicin—urinary bladder cancer	0.00083	0.0014	CcSEcCtD
Lacosamide—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000826	0.00139	CcSEcCtD
Lacosamide—Rash—Fluorouracil—urinary bladder cancer	0.000825	0.00139	CcSEcCtD
Lacosamide—Dermatitis—Fluorouracil—urinary bladder cancer	0.000825	0.00139	CcSEcCtD
Lacosamide—Headache—Fluorouracil—urinary bladder cancer	0.00082	0.00138	CcSEcCtD
Lacosamide—Asthenia—Etoposide—urinary bladder cancer	0.000816	0.00138	CcSEcCtD
Lacosamide—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000816	0.00138	CcSEcCtD
Lacosamide—Immune system disorder—Epirubicin—urinary bladder cancer	0.00081	0.00137	CcSEcCtD
Lacosamide—Pruritus—Etoposide—urinary bladder cancer	0.000804	0.00136	CcSEcCtD
Lacosamide—Nausea—Gemcitabine—urinary bladder cancer	0.000791	0.00134	CcSEcCtD
Lacosamide—Vomiting—Cisplatin—urinary bladder cancer	0.000789	0.00133	CcSEcCtD
Lacosamide—Vision blurred—Methotrexate—urinary bladder cancer	0.000786	0.00133	CcSEcCtD
Lacosamide—Mental disorder—Epirubicin—urinary bladder cancer	0.000786	0.00133	CcSEcCtD
Lacosamide—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000785	0.00132	CcSEcCtD
Lacosamide—Rash—Cisplatin—urinary bladder cancer	0.000783	0.00132	CcSEcCtD
Lacosamide—Dermatitis—Cisplatin—urinary bladder cancer	0.000782	0.00132	CcSEcCtD
Lacosamide—Erythema—Epirubicin—urinary bladder cancer	0.000781	0.00132	CcSEcCtD
Lacosamide—Diarrhoea—Etoposide—urinary bladder cancer	0.000778	0.00131	CcSEcCtD
Lacosamide—Nausea—Fluorouracil—urinary bladder cancer	0.000778	0.00131	CcSEcCtD
Lacosamide—Eye disorder—Doxorubicin—urinary bladder cancer	0.000776	0.00131	CcSEcCtD
Lacosamide—Tinnitus—Doxorubicin—urinary bladder cancer	0.000774	0.00131	CcSEcCtD
Lacosamide—Anaemia—Methotrexate—urinary bladder cancer	0.000771	0.0013	CcSEcCtD
Lacosamide—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.00077	0.0013	CcSEcCtD
Lacosamide—Flatulence—Epirubicin—urinary bladder cancer	0.000769	0.0013	CcSEcCtD
Lacosamide—Dizziness—Etoposide—urinary bladder cancer	0.000752	0.00127	CcSEcCtD
Lacosamide—Muscle spasms—Epirubicin—urinary bladder cancer	0.000751	0.00127	CcSEcCtD
Lacosamide—Immune system disorder—Doxorubicin—urinary bladder cancer	0.00075	0.00127	CcSEcCtD
Lacosamide—Vertigo—Methotrexate—urinary bladder cancer	0.00075	0.00127	CcSEcCtD
Lacosamide—Nausea—Cisplatin—urinary bladder cancer	0.000737	0.00124	CcSEcCtD
Lacosamide—Vision blurred—Epirubicin—urinary bladder cancer	0.000736	0.00124	CcSEcCtD
Lacosamide—Mental disorder—Doxorubicin—urinary bladder cancer	0.000727	0.00123	CcSEcCtD
Lacosamide—Vomiting—Etoposide—urinary bladder cancer	0.000723	0.00122	CcSEcCtD
Lacosamide—Erythema—Doxorubicin—urinary bladder cancer	0.000723	0.00122	CcSEcCtD
Lacosamide—Anaemia—Epirubicin—urinary bladder cancer	0.000722	0.00122	CcSEcCtD
Lacosamide—Agitation—Epirubicin—urinary bladder cancer	0.000718	0.00121	CcSEcCtD
Lacosamide—Rash—Etoposide—urinary bladder cancer	0.000717	0.00121	CcSEcCtD
Lacosamide—Dermatitis—Etoposide—urinary bladder cancer	0.000716	0.00121	CcSEcCtD
Lacosamide—Headache—Etoposide—urinary bladder cancer	0.000712	0.0012	CcSEcCtD
Lacosamide—Flatulence—Doxorubicin—urinary bladder cancer	0.000712	0.0012	CcSEcCtD
Lacosamide—Chest pain—Methotrexate—urinary bladder cancer	0.00071	0.0012	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000706	0.00119	CcSEcCtD
Lacosamide—Discomfort—Methotrexate—urinary bladder cancer	0.000702	0.00118	CcSEcCtD
Lacosamide—Vertigo—Epirubicin—urinary bladder cancer	0.000702	0.00118	CcSEcCtD
Lacosamide—Syncope—Epirubicin—urinary bladder cancer	0.0007	0.00118	CcSEcCtD
Lacosamide—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000695	0.00117	CcSEcCtD
Lacosamide—Palpitations—Epirubicin—urinary bladder cancer	0.00069	0.00117	CcSEcCtD
Lacosamide—Confusional state—Methotrexate—urinary bladder cancer	0.000687	0.00116	CcSEcCtD
Lacosamide—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000686	0.00116	CcSEcCtD
Lacosamide—Vision blurred—Doxorubicin—urinary bladder cancer	0.000681	0.00115	CcSEcCtD
Lacosamide—Nausea—Etoposide—urinary bladder cancer	0.000675	0.00114	CcSEcCtD
Lacosamide—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000668	0.00113	CcSEcCtD
Lacosamide—Anaemia—Doxorubicin—urinary bladder cancer	0.000668	0.00113	CcSEcCtD
Lacosamide—Chest pain—Epirubicin—urinary bladder cancer	0.000665	0.00112	CcSEcCtD
Lacosamide—Agitation—Doxorubicin—urinary bladder cancer	0.000664	0.00112	CcSEcCtD
Lacosamide—Skin disorder—Methotrexate—urinary bladder cancer	0.000661	0.00112	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.00066	0.00111	CcSEcCtD
Lacosamide—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000658	0.00111	CcSEcCtD
Lacosamide—Discomfort—Epirubicin—urinary bladder cancer	0.000657	0.00111	CcSEcCtD
Lacosamide—Dry mouth—Epirubicin—urinary bladder cancer	0.00065	0.0011	CcSEcCtD
Lacosamide—Vertigo—Doxorubicin—urinary bladder cancer	0.000649	0.0011	CcSEcCtD
Lacosamide—Syncope—Doxorubicin—urinary bladder cancer	0.000648	0.00109	CcSEcCtD
Lacosamide—Confusional state—Epirubicin—urinary bladder cancer	0.000643	0.00108	CcSEcCtD
Lacosamide—Palpitations—Doxorubicin—urinary bladder cancer	0.000639	0.00108	CcSEcCtD
Lacosamide—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000635	0.00107	CcSEcCtD
Lacosamide—Shock—Epirubicin—urinary bladder cancer	0.000627	0.00106	CcSEcCtD
Lacosamide—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000625	0.00106	CcSEcCtD
Lacosamide—Skin disorder—Epirubicin—urinary bladder cancer	0.000619	0.00105	CcSEcCtD
Lacosamide—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000616	0.00104	CcSEcCtD
Lacosamide—Insomnia—Methotrexate—urinary bladder cancer	0.000616	0.00104	CcSEcCtD
Lacosamide—Chest pain—Doxorubicin—urinary bladder cancer	0.000615	0.00104	CcSEcCtD
Lacosamide—Paraesthesia—Methotrexate—urinary bladder cancer	0.000612	0.00103	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000611	0.00103	CcSEcCtD
Lacosamide—Discomfort—Doxorubicin—urinary bladder cancer	0.000608	0.00103	CcSEcCtD
Lacosamide—Somnolence—Methotrexate—urinary bladder cancer	0.000605	0.00102	CcSEcCtD
Lacosamide—Dry mouth—Doxorubicin—urinary bladder cancer	0.000602	0.00102	CcSEcCtD
Lacosamide—Dyspepsia—Methotrexate—urinary bladder cancer	0.000599	0.00101	CcSEcCtD
Lacosamide—Confusional state—Doxorubicin—urinary bladder cancer	0.000595	0.001	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000588	0.000993	CcSEcCtD
Lacosamide—Fatigue—Methotrexate—urinary bladder cancer	0.000587	0.000991	CcSEcCtD
Lacosamide—Shock—Doxorubicin—urinary bladder cancer	0.00058	0.000979	CcSEcCtD
Lacosamide—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000578	0.000976	CcSEcCtD
Lacosamide—Insomnia—Epirubicin—urinary bladder cancer	0.000576	0.000973	CcSEcCtD
Lacosamide—Skin disorder—Doxorubicin—urinary bladder cancer	0.000573	0.000967	CcSEcCtD
Lacosamide—Paraesthesia—Epirubicin—urinary bladder cancer	0.000572	0.000966	CcSEcCtD
Lacosamide—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.00057	0.000962	CcSEcCtD
Lacosamide—Somnolence—Epirubicin—urinary bladder cancer	0.000567	0.000957	CcSEcCtD
Lacosamide—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000561	0.000947	CcSEcCtD
Lacosamide—Dyspepsia—Epirubicin—urinary bladder cancer	0.000561	0.000947	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00055	0.000929	CcSEcCtD
Lacosamide—Fatigue—Epirubicin—urinary bladder cancer	0.000549	0.000928	CcSEcCtD
Lacosamide—Constipation—Epirubicin—urinary bladder cancer	0.000545	0.00092	CcSEcCtD
Lacosamide—Urticaria—Methotrexate—urinary bladder cancer	0.000541	0.000913	CcSEcCtD
Lacosamide—Body temperature increased—Methotrexate—urinary bladder cancer	0.000538	0.000909	CcSEcCtD
Lacosamide—Insomnia—Doxorubicin—urinary bladder cancer	0.000533	0.0009	CcSEcCtD
Lacosamide—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00053	0.000894	CcSEcCtD
Lacosamide—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000525	0.000887	CcSEcCtD
Lacosamide—Somnolence—Doxorubicin—urinary bladder cancer	0.000524	0.000885	CcSEcCtD
Lacosamide—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000519	0.000876	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000509	0.00086	CcSEcCtD
Lacosamide—Fatigue—Doxorubicin—urinary bladder cancer	0.000508	0.000858	CcSEcCtD
Lacosamide—Urticaria—Epirubicin—urinary bladder cancer	0.000506	0.000855	CcSEcCtD
Lacosamide—Constipation—Doxorubicin—urinary bladder cancer	0.000504	0.000851	CcSEcCtD
Lacosamide—Body temperature increased—Epirubicin—urinary bladder cancer	0.000504	0.000851	CcSEcCtD
Lacosamide—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000502	0.000847	CcSEcCtD
Lacosamide—CA3—Metabolism—ENO2—urinary bladder cancer	0.000491	0.00342	CbGpPWpGaD
Lacosamide—Asthenia—Methotrexate—urinary bladder cancer	0.000489	0.000825	CcSEcCtD
Lacosamide—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000486	0.00082	CcSEcCtD
Lacosamide—CA4—Metabolism—NAT1—urinary bladder cancer	0.000486	0.00338	CbGpPWpGaD
Lacosamide—CA4—Metabolism—GSTO2—urinary bladder cancer	0.000486	0.00338	CbGpPWpGaD
Lacosamide—Pruritus—Methotrexate—urinary bladder cancer	0.000482	0.000813	CcSEcCtD
Lacosamide—CA9—Cellular responses to stress—GSTP1—urinary bladder cancer	0.00048	0.00334	CbGpPWpGaD
Lacosamide—CA3—Metabolism—GSTT1—urinary bladder cancer	0.000476	0.00331	CbGpPWpGaD
Lacosamide—CA1—C-MYB transcription factor network—KRAS—urinary bladder cancer	0.000473	0.00329	CbGpPWpGaD
Lacosamide—CA1—Metabolism—GSTZ1—urinary bladder cancer	0.000471	0.00327	CbGpPWpGaD
Lacosamide—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00047	0.000793	CcSEcCtD
Lacosamide—Urticaria—Doxorubicin—urinary bladder cancer	0.000468	0.000791	CcSEcCtD
Lacosamide—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000466	0.000787	CcSEcCtD
Lacosamide—Diarrhoea—Methotrexate—urinary bladder cancer	0.000466	0.000787	CcSEcCtD
Lacosamide—CA2—Metabolism—GSTO2—urinary bladder cancer	0.000465	0.00324	CbGpPWpGaD
Lacosamide—CA2—Metabolism—NAT1—urinary bladder cancer	0.000465	0.00324	CbGpPWpGaD
Lacosamide—SCN10A—L1CAM interactions—EGFR—urinary bladder cancer	0.000465	0.00324	CbGpPWpGaD
Lacosamide—Asthenia—Epirubicin—urinary bladder cancer	0.000457	0.000772	CcSEcCtD
Lacosamide—CA9—Cellular responses to stress—CCNE1—urinary bladder cancer	0.000454	0.00316	CbGpPWpGaD
Lacosamide—Pruritus—Epirubicin—urinary bladder cancer	0.000451	0.000761	CcSEcCtD
Lacosamide—Dizziness—Methotrexate—urinary bladder cancer	0.00045	0.00076	CcSEcCtD
Lacosamide—CA1—Metabolism—GSTO2—urinary bladder cancer	0.000446	0.0031	CbGpPWpGaD
Lacosamide—CA1—Metabolism—NAT1—urinary bladder cancer	0.000446	0.0031	CbGpPWpGaD
Lacosamide—CA4—Metabolism—UGT2B7—urinary bladder cancer	0.000444	0.00309	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—SOD2—urinary bladder cancer	0.000442	0.00308	CbGpPWpGaD
Lacosamide—CA14—Metabolism—TYMP—urinary bladder cancer	0.000438	0.00304	CbGpPWpGaD
Lacosamide—Diarrhoea—Epirubicin—urinary bladder cancer	0.000436	0.000736	CcSEcCtD
Lacosamide—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000434	0.000733	CcSEcCtD
Lacosamide—Vomiting—Methotrexate—urinary bladder cancer	0.000433	0.000731	CcSEcCtD
Lacosamide—Rash—Methotrexate—urinary bladder cancer	0.000429	0.000725	CcSEcCtD
Lacosamide—Dermatitis—Methotrexate—urinary bladder cancer	0.000429	0.000724	CcSEcCtD
Lacosamide—Headache—Methotrexate—urinary bladder cancer	0.000427	0.00072	CcSEcCtD
Lacosamide—CA6—Metabolism—TYMP—urinary bladder cancer	0.000426	0.00297	CbGpPWpGaD
Lacosamide—CA2—Metabolism—UGT2B7—urinary bladder cancer	0.000426	0.00296	CbGpPWpGaD
Lacosamide—Asthenia—Doxorubicin—urinary bladder cancer	0.000423	0.000714	CcSEcCtD
Lacosamide—CA9—Cellular responses to stress—GPX1—urinary bladder cancer	0.000422	0.00294	CbGpPWpGaD
Lacosamide—Dizziness—Epirubicin—urinary bladder cancer	0.000421	0.000712	CcSEcCtD
Lacosamide—Pruritus—Doxorubicin—urinary bladder cancer	0.000417	0.000704	CcSEcCtD
Lacosamide—CA9—Metabolism—GSTZ1—urinary bladder cancer	0.000414	0.00288	CbGpPWpGaD
Lacosamide—CA1—Metabolism—UGT2B7—urinary bladder cancer	0.000408	0.00284	CbGpPWpGaD
Lacosamide—Vomiting—Epirubicin—urinary bladder cancer	0.000405	0.000684	CcSEcCtD
Lacosamide—Nausea—Methotrexate—urinary bladder cancer	0.000405	0.000683	CcSEcCtD
Lacosamide—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000403	0.000681	CcSEcCtD
Lacosamide—CA1—C-MYB transcription factor network—HRAS—urinary bladder cancer	0.000402	0.0028	CbGpPWpGaD
Lacosamide—Rash—Epirubicin—urinary bladder cancer	0.000402	0.000678	CcSEcCtD
Lacosamide—Dermatitis—Epirubicin—urinary bladder cancer	0.000401	0.000678	CcSEcCtD
Lacosamide—CA4—Metabolism—CYP4B1—urinary bladder cancer	0.0004	0.00278	CbGpPWpGaD
Lacosamide—Headache—Epirubicin—urinary bladder cancer	0.000399	0.000674	CcSEcCtD
Lacosamide—CA5B—Metabolism—TYMP—urinary bladder cancer	0.000398	0.00277	CbGpPWpGaD
Lacosamide—CA14—Metabolism—NAT2—urinary bladder cancer	0.000396	0.00275	CbGpPWpGaD
Lacosamide—CA3—Metabolism—NQO1—urinary bladder cancer	0.000396	0.00275	CbGpPWpGaD
Lacosamide—CA9—Metabolism—GSTO2—urinary bladder cancer	0.000392	0.00273	CbGpPWpGaD
Lacosamide—CA9—Metabolism—NAT1—urinary bladder cancer	0.000392	0.00273	CbGpPWpGaD
Lacosamide—Dizziness—Doxorubicin—urinary bladder cancer	0.00039	0.000658	CcSEcCtD
Lacosamide—CA6—Metabolism—NAT2—urinary bladder cancer	0.000386	0.00268	CbGpPWpGaD
Lacosamide—CA2—Metabolism—CYP4B1—urinary bladder cancer	0.000383	0.00267	CbGpPWpGaD
Lacosamide—Nausea—Epirubicin—urinary bladder cancer	0.000379	0.000639	CcSEcCtD
Lacosamide—CA4—Metabolism—SLC19A1—urinary bladder cancer	0.000378	0.00263	CbGpPWpGaD
Lacosamide—Vomiting—Doxorubicin—urinary bladder cancer	0.000375	0.000633	CcSEcCtD
Lacosamide—Rash—Doxorubicin—urinary bladder cancer	0.000372	0.000628	CcSEcCtD
Lacosamide—Dermatitis—Doxorubicin—urinary bladder cancer	0.000371	0.000627	CcSEcCtD
Lacosamide—Headache—Doxorubicin—urinary bladder cancer	0.000369	0.000624	CcSEcCtD
Lacosamide—CA4—Metabolism—PRSS3—urinary bladder cancer	0.000368	0.00256	CbGpPWpGaD
Lacosamide—CA1—Metabolism—CYP4B1—urinary bladder cancer	0.000367	0.00256	CbGpPWpGaD
Lacosamide—CA2—Metabolism—SLC19A1—urinary bladder cancer	0.000362	0.00252	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—NAT2—urinary bladder cancer	0.00036	0.0025	CbGpPWpGaD
Lacosamide—CA9—Metabolism—UGT2B7—urinary bladder cancer	0.000359	0.0025	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—NCOR1—urinary bladder cancer	0.000354	0.00246	CbGpPWpGaD
Lacosamide—CA2—Metabolism—PRSS3—urinary bladder cancer	0.000353	0.00245	CbGpPWpGaD
Lacosamide—Nausea—Doxorubicin—urinary bladder cancer	0.00035	0.000591	CcSEcCtD
Lacosamide—CA9—Cellular responses to stress—ATM—urinary bladder cancer	0.000349	0.00243	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—CDK4—urinary bladder cancer	0.000348	0.00242	CbGpPWpGaD
Lacosamide—CA1—Metabolism—SLC19A1—urinary bladder cancer	0.000347	0.00241	CbGpPWpGaD
Lacosamide—CA14—Metabolism—RRM2—urinary bladder cancer	0.000342	0.00238	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—NCOR1—urinary bladder cancer	0.000339	0.00236	CbGpPWpGaD
Lacosamide—CA1—Metabolism—PRSS3—urinary bladder cancer	0.000338	0.00235	CbGpPWpGaD
Lacosamide—CA6—Metabolism—RRM2—urinary bladder cancer	0.000333	0.00232	CbGpPWpGaD
Lacosamide—CA3—Metabolism—GSTP1—urinary bladder cancer	0.00033	0.0023	CbGpPWpGaD
Lacosamide—CA9—Metabolism—CYP4B1—urinary bladder cancer	0.000323	0.00225	CbGpPWpGaD
Lacosamide—CA14—Metabolism—ENO2—urinary bladder cancer	0.000316	0.0022	CbGpPWpGaD
Lacosamide—CA14—Metabolism—HPGDS—urinary bladder cancer	0.000316	0.0022	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—NCOR1—urinary bladder cancer	0.000314	0.00218	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—RRM2—urinary bladder cancer	0.000311	0.00216	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—RHOA—urinary bladder cancer	0.000309	0.00215	CbGpPWpGaD
Lacosamide—CA6—Metabolism—ENO2—urinary bladder cancer	0.000308	0.00215	CbGpPWpGaD
Lacosamide—CA6—Metabolism—HPGDS—urinary bladder cancer	0.000308	0.00215	CbGpPWpGaD
Lacosamide—CA14—Metabolism—GSTT1—urinary bladder cancer	0.000307	0.00213	CbGpPWpGaD
Lacosamide—CA3—Metabolism—TYMS—urinary bladder cancer	0.000307	0.00213	CbGpPWpGaD
Lacosamide—CA9—Metabolism—SLC19A1—urinary bladder cancer	0.000305	0.00212	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—CREBBP—urinary bladder cancer	0.000303	0.00211	CbGpPWpGaD
Lacosamide—CA3—Metabolism—NCOR1—urinary bladder cancer	0.000303	0.00211	CbGpPWpGaD
Lacosamide—CA3—Metabolism—GSTM1—urinary bladder cancer	0.000303	0.00211	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—RB1—urinary bladder cancer	0.000302	0.0021	CbGpPWpGaD
Lacosamide—CA6—Metabolism—GSTT1—urinary bladder cancer	0.000299	0.00208	CbGpPWpGaD
Lacosamide—CA9—Metabolism—PRSS3—urinary bladder cancer	0.000297	0.00207	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—RHOA—urinary bladder cancer	0.000296	0.00206	CbGpPWpGaD
Lacosamide—CA4—Metabolism—TYMP—urinary bladder cancer	0.000294	0.00205	CbGpPWpGaD
Lacosamide—CA3—Metabolism—GPX1—urinary bladder cancer	0.00029	0.00202	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—HPGDS—urinary bladder cancer	0.000288	0.002	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—ENO2—urinary bladder cancer	0.000288	0.002	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—ERBB2—urinary bladder cancer	0.000286	0.00199	CbGpPWpGaD
Lacosamide—CA3—Metabolism—ERCC2—urinary bladder cancer	0.000285	0.00198	CbGpPWpGaD
Lacosamide—CA2—Metabolism—TYMP—urinary bladder cancer	0.000282	0.00196	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—CDK4—urinary bladder cancer	0.000279	0.00194	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—GSTT1—urinary bladder cancer	0.000279	0.00194	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—RHOA—urinary bladder cancer	0.000274	0.00191	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—ERBB2—urinary bladder cancer	0.000274	0.0019	CbGpPWpGaD
Lacosamide—CA1—Metabolism—TYMP—urinary bladder cancer	0.00027	0.00188	CbGpPWpGaD
Lacosamide—CA3—Metabolism—MTHFR—urinary bladder cancer	0.000268	0.00187	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—CDK4—urinary bladder cancer	0.000267	0.00186	CbGpPWpGaD
Lacosamide—CA4—Metabolism—NAT2—urinary bladder cancer	0.000266	0.00185	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—CDKN2A—urinary bladder cancer	0.000266	0.00185	CbGpPWpGaD
Lacosamide—CA14—Metabolism—NQO1—urinary bladder cancer	0.000255	0.00177	CbGpPWpGaD
Lacosamide—CA2—Metabolism—NAT2—urinary bladder cancer	0.000255	0.00177	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—PPARG—urinary bladder cancer	0.000254	0.00177	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—ERBB2—urinary bladder cancer	0.000254	0.00176	CbGpPWpGaD
Lacosamide—CA6—Metabolism—NQO1—urinary bladder cancer	0.000249	0.00173	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—CDK4—urinary bladder cancer	0.000248	0.00172	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—MMP9—urinary bladder cancer	0.000246	0.00171	CbGpPWpGaD
Lacosamide—CA1—Metabolism—NAT2—urinary bladder cancer	0.000245	0.0017	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—CREBBP—urinary bladder cancer	0.000244	0.0017	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—PPARG—urinary bladder cancer	0.000243	0.00169	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—CXCL8—urinary bladder cancer	0.000241	0.00168	CbGpPWpGaD
Lacosamide—CA9—Metabolism—TYMP—urinary bladder cancer	0.000238	0.00165	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—MMP9—urinary bladder cancer	0.000235	0.00163	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—CREBBP—urinary bladder cancer	0.000233	0.00162	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—NQO1—urinary bladder cancer	0.000232	0.00161	CbGpPWpGaD
Lacosamide—CA4—Metabolism—RRM2—urinary bladder cancer	0.00023	0.0016	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—SRC—urinary bladder cancer	0.000226	0.00157	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—PPARG—urinary bladder cancer	0.000225	0.00157	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—RHOA—urinary bladder cancer	0.000221	0.00154	CbGpPWpGaD
Lacosamide—CA2—Metabolism—RRM2—urinary bladder cancer	0.00022	0.00153	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—MMP9—urinary bladder cancer	0.000218	0.00151	CbGpPWpGaD
Lacosamide—CA3—Metabolism—PPARG—urinary bladder cancer	0.000217	0.00151	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—CDKN1A—urinary bladder cancer	0.000217	0.00151	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—SRC—urinary bladder cancer	0.000217	0.00151	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—CREBBP—urinary bladder cancer	0.000216	0.0015	CbGpPWpGaD
Lacosamide—CA9—Metabolism—NAT2—urinary bladder cancer	0.000215	0.0015	CbGpPWpGaD
Lacosamide—CA14—Metabolism—GSTP1—urinary bladder cancer	0.000213	0.00148	CbGpPWpGaD
Lacosamide—CA4—Metabolism—ENO2—urinary bladder cancer	0.000213	0.00148	CbGpPWpGaD
Lacosamide—CA4—Metabolism—HPGDS—urinary bladder cancer	0.000213	0.00148	CbGpPWpGaD
Lacosamide—CA1—Metabolism—RRM2—urinary bladder cancer	0.000211	0.00147	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—RHOA—urinary bladder cancer	0.000211	0.00147	CbGpPWpGaD
Lacosamide—CA3—Metabolism—CREBBP—urinary bladder cancer	0.000209	0.00145	CbGpPWpGaD
Lacosamide—CA6—Metabolism—GSTP1—urinary bladder cancer	0.000207	0.00144	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—EP300—urinary bladder cancer	0.000207	0.00144	CbGpPWpGaD
Lacosamide—CA4—Metabolism—GSTT1—urinary bladder cancer	0.000206	0.00143	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—ERBB2—urinary bladder cancer	0.000204	0.00142	CbGpPWpGaD
Lacosamide—CA2—Metabolism—HPGDS—urinary bladder cancer	0.000204	0.00142	CbGpPWpGaD
Lacosamide—CA2—Metabolism—ENO2—urinary bladder cancer	0.000204	0.00142	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—SRC—urinary bladder cancer	0.000201	0.0014	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—EGFR—urinary bladder cancer	0.000198	0.00138	CbGpPWpGaD
Lacosamide—CA14—Metabolism—TYMS—urinary bladder cancer	0.000198	0.00138	CbGpPWpGaD
Lacosamide—CA2—Metabolism—GSTT1—urinary bladder cancer	0.000198	0.00138	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—RHOA—urinary bladder cancer	0.000196	0.00136	CbGpPWpGaD
Lacosamide—CA1—Metabolism—ENO2—urinary bladder cancer	0.000195	0.00136	CbGpPWpGaD
Lacosamide—CA14—Metabolism—NCOR1—urinary bladder cancer	0.000195	0.00136	CbGpPWpGaD
Lacosamide—CA14—Metabolism—GSTM1—urinary bladder cancer	0.000195	0.00136	CbGpPWpGaD
Lacosamide—CA1—Metabolism—HPGDS—urinary bladder cancer	0.000195	0.00136	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—ERBB2—urinary bladder cancer	0.000195	0.00136	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—GSTP1—urinary bladder cancer	0.000194	0.00135	CbGpPWpGaD
Lacosamide—CA6—Metabolism—TYMS—urinary bladder cancer	0.000193	0.00134	CbGpPWpGaD
Lacosamide—CA6—Metabolism—NCOR1—urinary bladder cancer	0.00019	0.00133	CbGpPWpGaD
Lacosamide—CA6—Metabolism—GSTM1—urinary bladder cancer	0.00019	0.00133	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—EGFR—urinary bladder cancer	0.00019	0.00132	CbGpPWpGaD
Lacosamide—CA1—Metabolism—GSTT1—urinary bladder cancer	0.00019	0.00132	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—KRAS—urinary bladder cancer	0.000187	0.0013	CbGpPWpGaD
Lacosamide—CA14—Metabolism—GPX1—urinary bladder cancer	0.000187	0.0013	CbGpPWpGaD
Lacosamide—CA9—Metabolism—RRM2—urinary bladder cancer	0.000186	0.00129	CbGpPWpGaD
Lacosamide—CA14—Metabolism—ERCC2—urinary bladder cancer	0.000184	0.00128	CbGpPWpGaD
Lacosamide—CA6—Metabolism—GPX1—urinary bladder cancer	0.000182	0.00127	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—ERBB2—urinary bladder cancer	0.000181	0.00126	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—TYMS—urinary bladder cancer	0.00018	0.00125	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—KRAS—urinary bladder cancer	0.000179	0.00125	CbGpPWpGaD
Lacosamide—CA6—Metabolism—ERCC2—urinary bladder cancer	0.000179	0.00125	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—GSTM1—urinary bladder cancer	0.000178	0.00124	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—NCOR1—urinary bladder cancer	0.000178	0.00124	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—EGFR—urinary bladder cancer	0.000176	0.00122	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—MMP9—urinary bladder cancer	0.000175	0.00122	CbGpPWpGaD
Lacosamide—CA14—Metabolism—MTHFR—urinary bladder cancer	0.000173	0.0012	CbGpPWpGaD
Lacosamide—CA9—Metabolism—HPGDS—urinary bladder cancer	0.000172	0.0012	CbGpPWpGaD
Lacosamide—CA9—Metabolism—ENO2—urinary bladder cancer	0.000172	0.0012	CbGpPWpGaD
Lacosamide—CA4—Metabolism—NQO1—urinary bladder cancer	0.000171	0.00119	CbGpPWpGaD
Lacosamide—CA3—Metabolism—PTGS2—urinary bladder cancer	0.000171	0.00119	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—GPX1—urinary bladder cancer	0.00017	0.00118	CbGpPWpGaD
Lacosamide—CA6—Metabolism—MTHFR—urinary bladder cancer	0.000168	0.00117	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—MMP9—urinary bladder cancer	0.000168	0.00117	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—ERCC2—urinary bladder cancer	0.000167	0.00116	CbGpPWpGaD
Lacosamide—CA9—Metabolism—GSTT1—urinary bladder cancer	0.000167	0.00116	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—EP300—urinary bladder cancer	0.000166	0.00116	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—KRAS—urinary bladder cancer	0.000166	0.00116	CbGpPWpGaD
Lacosamide—CA2—Metabolism—NQO1—urinary bladder cancer	0.000164	0.00114	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—SRC—urinary bladder cancer	0.000162	0.00112	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—HRAS—urinary bladder cancer	0.000159	0.00111	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—EP300—urinary bladder cancer	0.000159	0.00111	CbGpPWpGaD
Lacosamide—CA1—Metabolism—NQO1—urinary bladder cancer	0.000158	0.0011	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—MTHFR—urinary bladder cancer	0.000157	0.00109	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—MMP9—urinary bladder cancer	0.000155	0.00108	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—SRC—urinary bladder cancer	0.000155	0.00107	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—HRAS—urinary bladder cancer	0.000152	0.00106	CbGpPWpGaD
Lacosamide—CA3—Metabolism—PTEN—urinary bladder cancer	0.000149	0.00104	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—TP53—urinary bladder cancer	0.000148	0.00103	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—EP300—urinary bladder cancer	0.000147	0.00102	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—SRC—urinary bladder cancer	0.000143	0.000996	CbGpPWpGaD
Lacosamide—CA4—Metabolism—GSTP1—urinary bladder cancer	0.000143	0.000995	CbGpPWpGaD
Lacosamide—CA3—Metabolism—EP300—urinary bladder cancer	0.000142	0.000989	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—EGFR—urinary bladder cancer	0.000142	0.000985	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—HRAS—urinary bladder cancer	0.000141	0.000982	CbGpPWpGaD
Lacosamide—CA14—Metabolism—PPARG—urinary bladder cancer	0.00014	0.000975	CbGpPWpGaD
Lacosamide—CA9—Metabolism—NQO1—urinary bladder cancer	0.000139	0.000964	CbGpPWpGaD
Lacosamide—CA2—Metabolism—GSTP1—urinary bladder cancer	0.000137	0.000954	CbGpPWpGaD
Lacosamide—CA6—Metabolism—PPARG—urinary bladder cancer	0.000137	0.00095	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—EGFR—urinary bladder cancer	0.000135	0.000942	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—TNF—urinary bladder cancer	0.000135	0.000938	CbGpPWpGaD
Lacosamide—CA14—Metabolism—CREBBP—urinary bladder cancer	0.000135	0.000936	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—KRAS—urinary bladder cancer	0.000134	0.00093	CbGpPWpGaD
Lacosamide—CA4—Metabolism—TYMS—urinary bladder cancer	0.000133	0.000925	CbGpPWpGaD
Lacosamide—CA1—Metabolism—GSTP1—urinary bladder cancer	0.000131	0.000914	CbGpPWpGaD
Lacosamide—CA4—Metabolism—NCOR1—urinary bladder cancer	0.000131	0.000914	CbGpPWpGaD
Lacosamide—CA4—Metabolism—GSTM1—urinary bladder cancer	0.000131	0.000914	CbGpPWpGaD
Lacosamide—CA6—Metabolism—CREBBP—urinary bladder cancer	0.000131	0.000912	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—TNF—urinary bladder cancer	0.000129	0.000897	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—KRAS—urinary bladder cancer	0.000128	0.00089	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—PPARG—urinary bladder cancer	0.000127	0.000887	CbGpPWpGaD
Lacosamide—CA2—Metabolism—TYMS—urinary bladder cancer	0.000127	0.000887	CbGpPWpGaD
Lacosamide—CA2—Metabolism—NCOR1—urinary bladder cancer	0.000126	0.000876	CbGpPWpGaD
Lacosamide—CA2—Metabolism—GSTM1—urinary bladder cancer	0.000126	0.000876	CbGpPWpGaD
Lacosamide—CA4—Metabolism—GPX1—urinary bladder cancer	0.000126	0.000875	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—EGFR—urinary bladder cancer	0.000125	0.000873	CbGpPWpGaD
Lacosamide—CA4—Metabolism—ERCC2—urinary bladder cancer	0.000124	0.000859	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—CREBBP—urinary bladder cancer	0.000122	0.000852	CbGpPWpGaD
Lacosamide—CA1—Metabolism—TYMS—urinary bladder cancer	0.000122	0.00085	CbGpPWpGaD
Lacosamide—CA1—Metabolism—NCOR1—urinary bladder cancer	0.000121	0.00084	CbGpPWpGaD
Lacosamide—CA1—Metabolism—GSTM1—urinary bladder cancer	0.000121	0.00084	CbGpPWpGaD
Lacosamide—CA2—Metabolism—GPX1—urinary bladder cancer	0.000121	0.000839	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—TNF—urinary bladder cancer	0.000119	0.000831	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—KRAS—urinary bladder cancer	0.000119	0.000824	CbGpPWpGaD
Lacosamide—CA2—Metabolism—ERCC2—urinary bladder cancer	0.000118	0.000824	CbGpPWpGaD
Lacosamide—CA4—Metabolism—MTHFR—urinary bladder cancer	0.000116	0.000808	CbGpPWpGaD
Lacosamide—CA1—Metabolism—GPX1—urinary bladder cancer	0.000116	0.000805	CbGpPWpGaD
Lacosamide—CA9—Metabolism—GSTP1—urinary bladder cancer	0.000116	0.000804	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—HRAS—urinary bladder cancer	0.000114	0.000791	CbGpPWpGaD
Lacosamide—CA1—Metabolism—ERCC2—urinary bladder cancer	0.000114	0.00079	CbGpPWpGaD
Lacosamide—CA2—Metabolism—MTHFR—urinary bladder cancer	0.000111	0.000774	CbGpPWpGaD
Lacosamide—CA14—Metabolism—PTGS2—urinary bladder cancer	0.00011	0.000767	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—HRAS—urinary bladder cancer	0.000109	0.000756	CbGpPWpGaD
Lacosamide—CA9—Metabolism—TYMS—urinary bladder cancer	0.000107	0.000747	CbGpPWpGaD
Lacosamide—CA6—Metabolism—PTGS2—urinary bladder cancer	0.000107	0.000747	CbGpPWpGaD
Lacosamide—CA1—Metabolism—MTHFR—urinary bladder cancer	0.000107	0.000742	CbGpPWpGaD
Lacosamide—CA9—Metabolism—NCOR1—urinary bladder cancer	0.000106	0.000739	CbGpPWpGaD
Lacosamide—CA9—Metabolism—GSTM1—urinary bladder cancer	0.000106	0.000739	CbGpPWpGaD
Lacosamide—CA9—Metabolism—GPX1—urinary bladder cancer	0.000102	0.000707	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—HRAS—urinary bladder cancer	0.000101	0.000701	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—PTGS2—urinary bladder cancer	0.0001	0.000697	CbGpPWpGaD
Lacosamide—CA9—Metabolism—ERCC2—urinary bladder cancer	9.98e-05	0.000694	CbGpPWpGaD
Lacosamide—CA14—Metabolism—PTEN—urinary bladder cancer	9.61e-05	0.000669	CbGpPWpGaD
Lacosamide—CA4—Metabolism—PPARG—urinary bladder cancer	9.42e-05	0.000655	CbGpPWpGaD
Lacosamide—CA9—Metabolism—MTHFR—urinary bladder cancer	9.38e-05	0.000653	CbGpPWpGaD
Lacosamide—CA6—Metabolism—PTEN—urinary bladder cancer	9.37e-05	0.000652	CbGpPWpGaD
Lacosamide—CA14—Metabolism—EP300—urinary bladder cancer	9.17e-05	0.000638	CbGpPWpGaD
Lacosamide—CA4—Metabolism—CREBBP—urinary bladder cancer	9.05e-05	0.000629	CbGpPWpGaD
Lacosamide—CA2—Metabolism—PPARG—urinary bladder cancer	9.03e-05	0.000628	CbGpPWpGaD
Lacosamide—CA6—Metabolism—EP300—urinary bladder cancer	8.93e-05	0.000621	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—PTEN—urinary bladder cancer	8.74e-05	0.000608	CbGpPWpGaD
Lacosamide—CA2—Metabolism—CREBBP—urinary bladder cancer	8.67e-05	0.000603	CbGpPWpGaD
Lacosamide—CA1—Metabolism—PPARG—urinary bladder cancer	8.65e-05	0.000602	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—EP300—urinary bladder cancer	8.34e-05	0.00058	CbGpPWpGaD
Lacosamide—CA1—Metabolism—CREBBP—urinary bladder cancer	8.31e-05	0.000578	CbGpPWpGaD
Lacosamide—CA9—Metabolism—PPARG—urinary bladder cancer	7.61e-05	0.000529	CbGpPWpGaD
Lacosamide—CA4—Metabolism—PTGS2—urinary bladder cancer	7.41e-05	0.000515	CbGpPWpGaD
Lacosamide—CA9—Metabolism—CREBBP—urinary bladder cancer	7.31e-05	0.000508	CbGpPWpGaD
Lacosamide—CA2—Metabolism—PTGS2—urinary bladder cancer	7.1e-05	0.000494	CbGpPWpGaD
Lacosamide—CA1—Metabolism—PTGS2—urinary bladder cancer	6.81e-05	0.000474	CbGpPWpGaD
Lacosamide—CA4—Metabolism—PTEN—urinary bladder cancer	6.46e-05	0.000449	CbGpPWpGaD
Lacosamide—CA2—Metabolism—PTEN—urinary bladder cancer	6.19e-05	0.000431	CbGpPWpGaD
Lacosamide—CA4—Metabolism—EP300—urinary bladder cancer	6.16e-05	0.000429	CbGpPWpGaD
Lacosamide—CA9—Metabolism—PTGS2—urinary bladder cancer	5.99e-05	0.000416	CbGpPWpGaD
Lacosamide—CA1—Metabolism—PTEN—urinary bladder cancer	5.94e-05	0.000413	CbGpPWpGaD
Lacosamide—CA2—Metabolism—EP300—urinary bladder cancer	5.91e-05	0.000411	CbGpPWpGaD
Lacosamide—CA1—Metabolism—EP300—urinary bladder cancer	5.66e-05	0.000394	CbGpPWpGaD
Lacosamide—CA9—Metabolism—PTEN—urinary bladder cancer	5.22e-05	0.000363	CbGpPWpGaD
Lacosamide—CA9—Metabolism—EP300—urinary bladder cancer	4.98e-05	0.000346	CbGpPWpGaD
